I 
10,290.00
+2.90%
Close of 6 Nov 2026, in ILA
At a glance
Figures in ILS, from our data supplier.
Net income
ILS 2.73bn
FY2017FY2025
Free cash flow
−ILS 11.01bn
FY2017FY2025
Shareholders' equity
ILS 94.37bn
FY2017FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Gross profit | ILS 16.37bn | ILS 18.22bn | ILS 22.01bn | ILS 252.6m | ILS 183.3m | ILS 162.0m | ILS 148.4m | ILS 141.1m | ILS 161.2m |
| Research and development | ILS 827.9m | ILS 45.0m | ILS 37.1m | — | — | ILS 1.2m | ILS 1.8m | — | — |
| Operating income | ILS 4.23bn | ILS 8.97bn | ILS 13.61bn | ILS 178.1m | ILS 133.3m | ILS 103.6m | ILS 85.8m | ILS 96.0m | ILS 118.7m |
| Net income | ILS 2.73bn | ILS 6.57bn | ILS 9.68bn | ILS 126.4m | ILS 93.7m | ILS 70.7m | ILS 59.9m | ILS 48.8m | ILS 80.3m |
| Diluted earnings per share | 109.24 | 262.74 | 387.13 | 5.06 | 3.75 | 2.82 | 2.40 | 1.95 | 3.21 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | ILS 200.35bn | ILS 167.34bn | ILS 1.74bn | ILS 1.59bn | ILS 1.48bn | ILS 1.39bn | ILS 1.01bn | ILS 955.8m | — |
| Cash and short-term investments | ILS 37.73bn | ILS 32.82bn | ILS 418.2m | ILS 344.3m | ILS 492.4m | ILS 529.0m | ILS 244.8m | ILS 174.6m | — |
| Total liabilities | ILS 105.44bn | ILS 70.48bn | ILS 811.0m | ILS 727.4m | ILS 724.4m | ILS 634.1m | ILS 635.2m | ILS 607.6m | — |
| Debt | ILS 51.44bn | ILS 344.1m | ILS 423.2m | ILS 343.7m | ILS 228.1m | ILS 219.8m | ILS 219.8m | ILS 174.1m | — |
| Shareholders' equity | ILS 94.37bn | ILS 96.19bn | ILS 927.2m | ILS 857.2m | ILS 750.0m | ILS 726.8m | ILS 347.7m | ILS 332.4m | — |
| Shares outstanding | 25m | 25m | 25m | 25m | 25m | 25m | 25m | 25m | 25m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | |
|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | ILS 15.00bn | ILS 20.07bn | ILS 18.03bn | ILS 24.8m | ILS 120.3m | ILS 82.4m | ILS 144.4m | ILS 185.3m | ILS 110.4m |
| Capital spending | −ILS 26.01bn | −ILS 20.06bn | −ILS 16.19bn | −ILS 86.2m | −ILS 111.8m | −ILS 112.0m | −ILS 63.5m | −ILS 130.6m | −ILS 49.1m |
| Free cash flow | −ILS 11.01bn | ILS 9.6m | ILS 1.84bn | −ILS 61.4m | ILS 8.4m | −ILS 29.7m | ILS 80.8m | ILS 54.8m | ILS 61.3m |
| Dividends paid | −ILS 2.00bn | −ILS 3.00bn | −ILS 3.50bn | −ILS 30.0m | −ILS 25.0m | −ILS 17.0m | −ILS 34.0m | −ILS 42.6m | −ILS 96.4m |
Latest quarters
By quarter end
| Jun 2026 | Mar 2026 | Dec 2025 | Sept 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sept 2024 | |
|---|---|---|---|---|---|---|---|---|
| Gross profit | ILS 6.32bn | ILS 5.33bn | ILS 4.45bn | ILS 4.94bn | ILS 3.43bn | ILS 4.30bn | ILS 5.71bn | ILS 4.97bn |
| Operating income | ILS 2.88bn | ILS 1.96bn | ILS 1.42bn | ILS 1.34bn | ILS 58.6m | ILS 1.68bn | ILS 2.56bn | ILS 2.28bn |
| Net income | ILS 1.56bn | ILS 1.05bn | ILS 597.5m | ILS 898.3m | ILS 68.7m | ILS 1.17bn | ILS 1.78bn | ILS 1.79bn |
| Diluted earnings per share | 62.40 | 41.98 | 23.90 | 35.93 | 2.75 | 46.66 | 71.22 | 71.56 |
| Cash from operations | −ILS 2.88bn | −ILS 53.0m | ILS 12.98bn | −ILS 2.48bn | −ILS 6.06bn | ILS 10.56bn | ILS 14.88bn | −ILS 1.74bn |
| Capital spending | −ILS 2.67bn | −ILS 3.82bn | −ILS 5.52bn | −ILS 5.68bn | −ILS 8.30bn | −ILS 6.86bn | −ILS 10.96bn | −ILS 4.19bn |
| Free cash flow | −ILS 5.55bn | −ILS 3.87bn | ILS 7.46bn | −ILS 8.16bn | −ILS 14.36bn | ILS 3.70bn | ILS 3.92bn | −ILS 5.93bn |
| Total assets | ILS 223.54bn | ILS 215.58bn | ILS 200.35bn | ILS 215.80bn | ILS 215.91bn | ILS 208.52bn | ILS 167.34bn | ILS 176.37bn |
| Cash and short-term investments | ILS 40.54bn | ILS 41.49bn | ILS 37.73bn | ILS 41.07bn | ILS 45.68bn | ILS 54.68bn | ILS 32.82bn | ILS 40.49bn |
| Debt | ILS 38.76bn | ILS 47.05bn | ILS 40.48bn | ILS 61.48bn | ILS 57.30bn | ILS 43.87bn | ILS 26.37bn | ILS 35.47bn |
| Shareholders' equity | ILS 94.08bn | ILS 93.76bn | ILS 94.37bn | ILS 94.87bn | ILS 94.18bn | ILS 97.68bn | ILS 96.19bn | ILS 95.26bn |
Financial ratios
Data as of 20 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Gross margin | 10.4% | 13.9% | 14.4% | 17.1% | 19.4% | 21.2% | — |
| Operating margin | 3.9% | 8.1% | 9.1% | 11.3% | 15.3% | 13.9% | — |
| Net margin | 1.7% | 5.0% | 6.3% | 8.6% | 9.9% | 9.2% | — |
| Return on equity | 2.9% | 6.8% | 10.4% | 14.7% | 12.5% | 9.7% | — |
| Return on assets | 1.4% | 3.9% | 5.5% | 7.9% | 6.3% | 5.1% | — |
| Free cash flow yield | 0.2% | 0.2% | 0.1% | 0.0% | 0.1% | 0.1% | — |
| Revenue growth | 20.6% | -14.6% | 3.7% | 56.2% | 23.5% | 3.2% | — |
| Earnings growth | -58.4% | -32.1% | -23.5% | 34.9% | 32.6% | 18.0% | — |
| Current ratio | 1.15x | 1.55x | 1.85x | 1.74x | 1.67x | 1.82x | — |
| Debt to equity | 0.55x | 0.27x | 0.37x | 0.32x | 0.26x | 0.26x | — |
| Equity ratio | 47.1% | 57.5% | 53.1% | 53.9% | 50.7% | 52.4% | — |
| Interest coverage | 2.09x | 4.38x | 7.55x | 9.89x | 15.65x | 36.85x | — |
| R&D as a share of sales | 0.5% | 0.0% | 0.0% | — | — | 0.2% | 0.2% |
| Buybacks as a share of market value | 0.0% | -0.0% | 0.0% | 0.0% | 0.1% | -0.1% | — |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 373.5% | 189.7% | — |
| Operating income | 187.5% | 110.0% | — |
| Net income | 178.5% | 107.7% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Gross margin | 12.0% | 12.8% | 12.9% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Price to earnings | 1.5 | 0.4 | 0.2 | 16.0 | 21.1 | 21.8 |
| Price to sales | 0.0 | 0.0 | 0.0 | 1.4 | 2.1 | 2.0 |
Dividends and splits
Per share, in the currency the company pays
Paid for 5 years. Last went ex-dividend on 25 Mar 2026.
| FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Paid in the year | 40.00 | 0.80 | 1.20 | 1.40 | 1.20 | 1.00 |
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.